Evidence map›Paper›PMID 26458230›Full record

ArticleAngewandte Chemie (International ed. in English)2015

Synthesis and Use of a Phosphonate Amidine to Generate an Anti-Phosphoarginine-Specific Antibody.

Jakob Fuhrmann, Venkataraman Subramanian, Paul R Thompson

Open access · greenAbstract read
In one paragraph

Article in Angewandte Chemie (International ed. in English), 2015. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 13 papers.

0numbers the graph read from it
0cells of the map it votes in
13citing papers in PubMed
2.6field-weighted citation impact, top 11% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

13 citing papers in PubMed, 45 citations in OpenAlex.

  1. Article
  2. [Progress in enrichment methods for proteinSe pu = Chinese journal of chromatography · 2024
    Review
  3. Review
  4. Article
  5. Article
  6. Synthesis and Evaluation of Non-Hydrolyzable Phospho-Lysine Peptide Mimics.Chemistry (Weinheim an der Bergstrasse, Germany) · 2021
    Article
  7. Article
  8. Article
  9. Article
  10. Article
  11. Spectral Library Based Analysis of Arginine Phosphorylations inMolecular & cellular proteomics : MCP · 2018
    Article
  12. Article
  13. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

3 authors at 3 institutions in 1 country.

Jakob FuhrmannDepartment of Chemistry, The Scripps Research Institute, 130 Scripps Way, Jupiter, FL 33458 (USA). jfuhrman@scripps.edu.
Venkataraman SubramanianDepartment of Biochemistry and Molecular Pharmacology, UMass Medical School, 364 Plantation Street, Worcester, MA 01605 (USA).
Paul R ThompsonDepartment of Biochemistry and Molecular Pharmacology, UMass Medical School, 364 Plantation Street, Worcester, MA 01605 (USA). paul.thompson@umassmed.edu.
Interface (United States) · USScripps Research Institute · USUniversity of Massachusetts Chan Medical School · US

Funding

Haloacetamidine based inactivators of Protein Arginine Deiminase 4R01GM079357 · NIGMS · UNIV OF MASSACHUSETTS MED SCH WORCESTER · PI THOMPSON, PAUL R · 2007 to 2016
$3.3M
Austrian Science Fund FWF J 3548NIGMS NIH HHS GM079357NIGMS NIH HHS R01 GM079357
6 · The paper itself

Abstract

Protein arginine phosphorylation is a post-translational modification (PTM) that is important for bacterial growth and virulence. Despite its biological relevance, the intrinsic acid lability of phosphoarginine (pArg) has impaired studies of this novel PTM. Herein, we report for the first time the development of phosphonate amidines and sulfonate amidines as isosteres of pArg and then use these mimics as haptens to develop the first high-affinity sequence independent anti-pArg specific antibody. Employing this anti-pArg antibody, we further showed that arginine phosphorylation is induced in Bacillus subtilis during oxidative stress. Overall, we expect this antibody to see widespread use in analyzing the biological significance of arginine phosphorylation. Additionally, the chemistry reported here will facilitate the generation of pArg mimetics as highly potent inhibitors of the enzymes that catalyze arginine phosphorylation/dephosphorylation.

Indexed as

Antibody SpecificityAmidinesAntibodiesArginineBacillus subtilisHaptensMolecular StructureOrganophosphonatesOrganophosphorus CompoundsOxidative StressPhosphorylationAmidinesAntibodiesArginineHaptensOrganophosphonatesOrganophosphorus Compoundsphospho-L-arginineantibodieshaptensN-phosphorylationphosphoargininephosphonate amidine

Identifiers

PMID26458230
PMCPMC4715515
OpenAlexW2134636139

What OpenQuestion holds

Textmetadata
LicenceTDM
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.